Herd immunity or suppression strategy to combat COVID-19

被引:24
|
作者
Jung, F. [1 ]
Krieger, V. [2 ]
Hufert, F. T. [3 ,4 ]
Kuepper, J. -H. [1 ,4 ]
机构
[1] Brandenburg Tech Univ Cottbus, Inst Biotechnol, Mol Cell Biol, Senftenberg, Germany
[2] TMM AG Boblingen, Dept Head Lab Planning & Norming Informat Managem, Boblingen, Germany
[3] Brandenburg Med Sch, Inst Microbiol & Virol, Senftenberg, Germany
[4] Brandenburg Med Sch Theodor Fontane & Univ Potsda, Joint Fac Brandenburg Univ Technol Cottbus Senfte, Fac Hlth Sci, Potsdam, Germany
关键词
COVID-19; strategy; Sweden; Taiwan; Germany;
D O I
10.3233/CH-209006
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Some months ago, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) broke out in Wuhan, China, and spread rapidly around the world. Some states, such as the Netherlands, Germany, Great Britain, Sweden and the USA initially focused on keeping the restrictions for economy and society as low as possible. The responsible authorities were of the opinion - and still are e.g. in Sweden - that it is sufficient enough to protect particularly vulnerable persons such as the elderly or people with pre-existing conditions. The idea behind this is that as soon as 60 to 70 percent of the population is infected with a pathogen, a so-called "herd immunity" has developed. However, the increasing numbers of deaths and modelling studies showed the expected overload of the hospitals. Therefore, most countries decided for a temporary lockdown with the exception of Sweden. Based on the number of the total population, three times more people died from COVID-19 in Sweden (2679 deaths per 10 million inhabitants) compared to Germany (6848 deaths per 80 million inhabitants). The comparison Sweden versus Taiwan is even worse because 1072 times more people died in Sweden based on the number of the population (6 deaths per 24 million inhabitants). In the face of the lack of an antiviral treatment and the lack of a protective vaccine one must state Taiwan has made the best out of the pandemic situation whereas Sweden failed completely.
引用
收藏
页码:13 / 17
页数:5
相关论文
共 50 条
  • [1] Can herd immunity be relied on as a strategy to combat COVID-19?
    Virk, Amrit
    Samdarshi, Narottam
    [J]. INTERNATIONAL JOURNAL OF HEALTH AND ALLIED SCIENCES, 2020, 9 : 73 - 76
  • [2] Herd immunity for COVID-19
    Burki, Talha Khan
    [J]. LANCET RESPIRATORY MEDICINE, 2021, 9 (02): : 135 - 136
  • [3] COVID-19 and Herd Immunity
    Alp, Sehnaz
    Altintas, Hakan
    [J]. FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI, 2021, 26 (02): : 232 - 237
  • [4] Herd immunity and COVID-19
    Chen, J.
    Ye, L.
    Zhou, M. -Y.
    Cheng, Y. -R.
    Wang, M. -W.
    Feng, Z. -H.
    [J]. EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (08) : 4064 - 4065
  • [5] COVID-19 and herd immunity
    Ashton, John
    [J]. JOURNAL OF THE ROYAL SOCIETY OF MEDICINE, 2022, 115 (02) : 76 - 77
  • [6] Role of Herd Immunity in COVID-19
    Ruchi
    Chakole, Swarupa
    Reddy, Himabindu
    Mehendale, Ashok
    [J]. JOURNAL OF RESEARCH IN MEDICAL AND DENTAL SCIENCE, 2022, 10 (08): : 258 - 262
  • [7] Digital herd immunity and COVID-19
    Bulchandani, Vir B.
    Shivam, Saumya
    Moudgalya, Sanjay
    Sondhi, S. L.
    [J]. PHYSICAL BIOLOGY, 2021, 18 (04)
  • [8] COVID-19, herd immunity and vaccine
    Tin, Sim Sai
    Wiwanitkit, Viroj
    [J]. INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2023, 14 (01)
  • [9] COVID-19: individual and herd immunity
    Bach, Jean-Francois
    Berche, Patrick
    Chatenoud, Lucienne
    Costagliola, Dominique
    Valleron, Alain-Jacques
    [J]. COMPTES RENDUS BIOLOGIES, 2021, 344 (01) : 7 - 18
  • [10] The dilemma of herd immunity for COVID-19
    Nejadghaderi, Seyed Aria
    Safiri, Saeid
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (05) : 2578 - 2579